Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Antonio Matas Hoces"'
Autor:
Antonio Olry de Labry Lima, Zuzana Špacírová, Silvia Fénix-Caballero, Antonio Matas Hoces, Adrián Sánchez Vegas, Manuel Cárdenas Aranzana, Jesús F. Sierra-Sánchez, María del Carmen Martínez Díaz, Emilio Jesús Alegre del Rey
Publikováno v:
Breast, Vol 58, Iss , Pp 27-33 (2021)
Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib treatment for patients with locally advanced or metastatic gBRCA + breast cancer from the perspect
Externí odkaz:
https://doaj.org/article/bf759a0faacb4bc48750cb2e55e3a759
Autor:
Antonio Olry de Labry Lima, Jorge Marcos Marcos, Alfonso Marquina Marquez, María de los Ángeles González Vera, Antonio Matas Hoces, Clara Bermúdez Tamayo
Publikováno v:
BMC Family Practice, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background There is a high prevalence of potentially inappropriate prescriptions in primary care. This is associated with more frequent adverse events, lower quality of life and more frequent visits to hospital accident & emergency departmen
Externí odkaz:
https://doaj.org/article/fb0cec238af74486980d0eeebedb2de8
Autor:
Jesús F. Sierra-Sánchez, Silvia Fénix-Caballero, Zuzana Špacírová, Manuel Cárdenas Aranzana, Adrián Sánchez Vegas, Emilio Jesús Alegre-Del Rey, Antonio Olry de Labry Lima, Antonio Matas Hoces, María del Carmen Martínez Díaz
Publikováno v:
Breast, Vol 60, Iss, Pp 302-(2021)
Breast, Vol 58, Iss, Pp 27-33 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 58, Iss, Pp 27-33 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast cancer is one of the most frequent malignancies. The aim of the article is to analyse the cost-utility ratio and budgetary impact of talazoparib treatment for patients with locally advanced or metastatic gBRCA + breast cancer from the perspect
Autor:
María de los Ángeles González Vera, Jorge Marcos Marcos, Antonio Matas Hoces, Antonio Olry de Labry Lima, Clara Bermúdez Tamayo, Alfonso Marquina Márquez
Publikováno v:
BMC Family Practice
RUA. Repositorio Institucional de la Universidad de Alicante
Universidad de Alicante (UA)
BMC Family Practice, Vol 21, Iss 1, Pp 1-12 (2020)
RUA. Repositorio Institucional de la Universidad de Alicante
Universidad de Alicante (UA)
BMC Family Practice, Vol 21, Iss 1, Pp 1-12 (2020)
Background There is a high prevalence of potentially inappropriate prescriptions in primary care. This is associated with more frequent adverse events, lower quality of life and more frequent visits to hospital accident & emergency departments. The a
Autor:
Antonio Matas Hoces, Julio González-Outón, Jesús Francisco Sierra Sánchez, Emilio Jesús Alegre-Del Rey, Vicente Gimeno Ballester, Antonio Olry de Labry Lima
Publikováno v:
Revista Española de Cardiología. 71:1027-1035
Resumen Introduccion y objetivos Analizar la razon de coste-efectividad y el impacto presupuestario del tratamiento con evolocumab (inhibidor de la PCSK9) para pacientes en prevencion secundaria en el Sistema Nacional de Salud espanol. Metodos Se rea
Autor:
Julio González-Outón, Antonio Matas Hoces, Jesús Francisco Sierra Sánchez, Emilio Jesús Alegre-Del Rey, Antonio Olry de Labry Lima, Vicente Gimeno Ballester
Publikováno v:
Revista Española de Cardiología (English Edition). 71:1027-1035
Introduction and objectives To analyze the cost-effectiveness ratio and budget impact of treatment with evolocumab (PCSK9 inhibitor) for patients in secondary prevention in the Spanish National Health System. Methods A budget impact analysis, decisio
Autor:
Vicente Gimeno Ballester, Esmeralda Ríos Sánchez, Antonio Olry de Labry Lima, Antonio Matas Hoces, Emilio Jesús Alegre-Del Rey
Publikováno v:
Bone Marrow Transplantation. 55:853-854
Autor:
Rafael Ríos Tamayo, Esmeralda Ríos Sánchez, Antonio Matas Hoces, Leticia García Mochón, Vicente Gimeno-Ballester, Antonio Olry de Labry Lima, Emilio Jesús Alegre-Del Rey, David Epstein
The objective of this article is to analyze the ratio of cost-effectiveness and budgetary impact of lenalidomide treatment in patients with multiple myeloma who have undergone autologous transplant in Spain. The analyses were based on clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e384db8b0142948ff956ae0041f88f1d
https://hdl.handle.net/10668/14046
https://hdl.handle.net/10668/14046
Autor:
Antonio, Olry de Labry Lima, Vicente, Gimeno-Ballester, Rafael, Ríos Tamayo, David, Epstein, Antonio, Matas Hoces, Esmeralda, Ríos Sánchez, Leticia, García Mochón, Emilio Jesús, Alegre-Del Rey
Publikováno v:
Bone marrow transplantation. 54(11)
The objective of this article is to analyze the ratio of cost-effectiveness and budgetary impact of lenalidomide treatment in patients with multiple myeloma who have undergone autologous transplant in Spain. The analyses were based on clinical trials
Autor:
Vicente Gimeno Ballester, Antonio Olry de Labry Lima, Antonio Matas Hoces, Emilio Jesús Alegre-Del Rey
Publikováno v:
Revista Española de Cardiología. 71:1090